Alphatec Holdings (ATEC) Financials: History & Chart

Alphatec Holdings, Inc.(ATEC)

Medical - Devices · Carlsbad, CA

$10.77+0.05 (+0.47%)

Delayed quote: Oct 6, 2026, 9:30 AM EDT

About Alphatec Holdings, Inc.

Alphatec Holdings, Inc. is a medical technology firm dedicated to engineering and advancing solutions for the surgical management of spinal conditions. Its product array includes the Alpha InformatiX platform, notably the SafeOp Neural InformatiX System, which is engineered to reduce the likelihood of nerve injury during surgery. For access and positioning, Alphatec offers systems such as the Sigma transforaminal lumbar interbody fusion pedicle-based access system, the Sigma PTP Access and Patient Positioning System, and the Squadron lateral retractor, all designed to optimize surgical outcomes. The company's robust line of spinal fixation devices features the Invictus Spinal Fixation System, capable of addressing various thoracolumbar pathologies, alongside its minimally invasive SingleStep System and adaptable Modular Fixation Systems, which enhance screw modularity. Further fixation options include the OsseoScrew system for spinal column restoration and the comprehensive Arsenal spinal fixation platform, catering to a spectrum of degenerative to deformity procedures. Alphatec also provides anterior lumbar plating solutions like the Aspida Anterior Lumbar Plating System for interbody fusion and the AMP Anti-Migration Plate, in addition to cervical fixation options such as the OCT Spinal Fixation System, the Trestle Luxe Anterior Cervical Plate System, and the Insignia Anterior Cervical Plate System. Its portfolio extends to interbody implants, including IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Implants. A comprehensive suite of biologics is also available, featuring Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier. The company additionally offers EOS imaging products. Alphatec Holdings markets its diverse product range throughout the United States via a network of independent distributors and its own direct sales force. Established in 1990, the company's headquarters are located in Carlsbad, California.

Carlsbad, CA

913 employees

www.atecspine.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Patrick S. Miles

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	815.05M	213.51M	192.11M	212.93M	196.50M	185.54M	169.18M	176.79M	150.72M
Cost of Goods Sold	275.92M	59.41M	74.77M	82.54M	59.20M	56.44M	53.18M	55.20M	47.99M
Gross Profit	539.13M	154.10M	117.34M	130.39M	137.30M	129.10M	116.00M	121.59M	102.73M
Gross Profit Margin	66.1%	72.2%	61.1%	61.2%	69.9%	69.6%	68.6%	68.8%	68.2%
Total Operating Expenses	584.39M	156.01M	139.40M	135.75M	153.23M	142.19M	160.29M	145.41M	136.43M
Research & Development	77.14M	18.17M	17.56M	22.73M	18.68M	18.28M	16.58M	23.24M	20.36M
Selling, General & Administrative	508.83M	134.00M	137.06M	113.47M	124.30M	118.51M	127.02M	114.54M	109.20M
Operating Income (EBIT)	-45.26M	-1.91M	-22.06M	-5.36M	-15.93M	-13.09M	-44.29M	-23.82M	-33.70M
Operating Margin	-5.6%	-0.9%	-11.5%	-2.5%	-8.1%	-7.1%	-26.2%	-13.5%	-22.4%
Income Before Tax (EBT)	-109.73M	-25.63M	-33.86M	-21.75M	-28.50M	-41.18M	-51.97M	-32.89M	-39.65M
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	40.75M	10.96M	11.72M	5.18M	12.88M	12.31M	7.84M	7.15M	6.57M
Other Income/Expense	-64.47M	-23.72M	-11.80M	-16.39M	-12.57M	-28.10M	-7.68M	-9.07M	-5.95M
Net Income	-109.99M	-25.78M	-33.91M	-21.73M	-28.58M	-41.14M	-51.91M	-33.33M	-39.62M
Income Tax Expense	262K	156K	50K	-18K	74K	-37K	-64K	441K	-36K
Net Profit Margin	-13.5%	-12.1%	-17.6%	-10.2%	-14.5%	-22.2%	-30.7%	-18.9%	-26.3%
EBITDA	37.18M	19.21M	-1.60M	15.12M	4.45M	7.44M	-23.11M	-2.41M	-11.78M
EBITDA Margin	4.6%	9.0%	-0.8%	7.1%	2.3%	4.0%	-13.7%	-1.4%	-7.8%
Depreciation & Amortization	82.44M	21.12M	20.46M	20.48M	20.38M	20.52M	21.18M	21.41M	21.92M
EPS Basic	-0.72	-0.16	-0.22	-0.15	-0.19	-0.27	-0.35	-0.23	-0.28
EPS Diluted	-0.72	-0.16	-0.22	-0.15	-0.19	-0.27	-0.35	-0.23	-0.28
Weighted Average Basic Shares	155.33M	155.33M	154.05M	150.06M	151.40M	149.91M	146.73M	142.95M	143.49M
Weighted Average Diluted Shares	155.33M	155.33M	154.05M	150.06M	151.40M	149.91M	146.73M	142.95M	143.49M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/30/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	764.15M	611.56M	482.26M	350.87M	243.21M	144.86M	113.43M	91.69M
Cost of Goods Sold	232.27M	187.30M	172.06M	117.81M	85.45M	42.36M	35.83M	28.46M
Gross Profit	531.89M	424.26M	310.20M	233.06M	157.76M	102.50M	77.59M	63.24M
Gross Profit Margin	69.6%	69.4%	64.3%	66.4%	64.9%	70.8%	68.4%	69.0%
Total Operating Expenses	614.02M	560.43M	483.60M	380.03M	285.82M	161.36M	124.87M	83.23M
Research & Development	76.27M	80.72M	70.11M	44.03M	32.02M	18.75M	13.85M	9.98M
Selling, General & Administrative	498.53M	450.20M	374.08M	300.01M	229.27M	129.16M	101.71M	72.51M
Operating Income (EBIT)	-82.13M	-136.17M	-173.40M	-146.97M	-128.06M	-58.86M	-47.28M	-22.44M
Operating Margin	-10.7%	-22.3%	-36.0%	-41.9%	-52.7%	-40.6%	-41.7%	-24.5%
Income Before Tax (EBT)	-143.40M	-162.07M	-186.91M	-152.01M	-144.16M	-78.85M	-57.14M	-30.17M
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	9.87M	N/A
Interest Expense	21.14M	24.88M	16.64M	5.50M	7.11M	12.37M	N/A	7.14M
Other Income/Expense	-61.27M	-25.90M	-13.52M	-5.03M	-16.11M	-19.99M	-9.87M	-7.73M
Net Income	-143.36M	-162.12M	-186.64M	-151.29M	-143.03M	-78.99M	-57.00M	-28.98M
Income Tax Expense	-45K	50K	-277K	-716K	-1.13M	145K	-239K	-1.36M
Net Profit Margin	-18.8%	-26.5%	-38.7%	-43.1%	-58.8%	-54.5%	-50.3%	-31.6%
EBITDA	435K	-52.85M	-113.71M	-103.05M	-97.88M	-47.23M	-38.77M	-15.65M
EBITDA Margin	0.1%	-8.6%	-23.6%	-29.4%	-40.2%	-32.6%	-34.2%	-17.1%
Depreciation & Amortization	82.56M	83.32M	59.68M	43.93M	30.17M	11.63M	8.51M	6.79M
EPS Basic	-0.96	-1.13	-1.54	-1.47	-1.50	-1.18	-1.09	-0.82
EPS Diluted	-0.96	-1.13	-1.54	-1.47	-1.50	-1.18	-1.09	-0.82
Weighted Average Basic Shares	150.06M	142.95M	121.24M	103.37M	96.20M	67.02M	52.23M	35.31M
Weighted Average Diluted Shares	150.06M	142.95M	121.24M	103.37M	96.20M	67.02M	52.23M	35.31M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.